Australia's largest stock trading and investment forum Australia's #1 stock forum

RNO

0.00%

4.0¢ rhinomed limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14

First 14 Last

Share
Profile

Follow
mathowa

1,201 Posts.

36

08/05/22

16:38

Post #: 61274871
Share

Originally posted by aventurine: ↑

The initial deal (MOU, LOI & Supply Agreement) is with BTNX the Canadian RAT manufacturer.

In Australia, SureScreen Australia is the distributor for BTNX. (I'm not sure if they are also the distributor for other countries/regions).

I think we are still awaiting approvals from Canada Health & Australian TGA for the BTNX RAT with the Rhinoswabs. What they announced in January was the MOU which was subject to TGA approval, not that they had TGA approval. The Supply Agreement (7/4/22) states they are still awaiting approval(s), but seem to be getting closer.

SureScreen Diagnostics is a leading UK supplier of RATs. In Australia SureScreen Australia provides their distribution as well.

It would appear that Rhinoswab(s) will soon be sold with the Surescreen RAT product in Australia as well.

I'm not sure why you'd think it doesn't look good?

I fail to see how being involved with two of the leading RAT suppliers in BTNX & SureScreen Diagnostics is a bad thing. Especially as they seem to have some existing agreements prior to RNO. They both seem to see potential in the Rhinoswab(s), most likely Junior. And they both seem to supply established markets other than the UK & Canada.

Also the BTNX deal has the stated minimum order quantities - but we don't know what the potential is above that.

imho - I think things are coming together.

Expand

TGA approval was a week ago, so why no announcement regarding it and a day after was the final of the retail entitlement. All the short fall was taken up by sophisticated investors. Call me a scept but time will tell.

RNO Price at posting: 18.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

Time for retail therapy in the shopping Scentre for some hot stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks